Analysis for the Combination Expression of CK20, FABP1 and MUC2 is Sensitive for the Prediction of Peritoneal Recurrence in Gastric Cancer

Japanese Journal of Clinical Oncology

Volumn 42, Issue 2, 2012, Pages 148-152

  Satoh, Yumiko ^a   Mori, Kazuhiko ^a   Kitano, Kentaro ^a   Kitayama, Joji ^b   Yokota, Hiromitsu ^a   Sasaki, Hiroki ^c   Uozaki, Hiroshi ^b   Fukayama, Masashi ^b   Seto, Yasuhiro ^a   Nagawa, Hirokazu ^b   Yatomi, Yutaka ^a,d   Takai, Daiya ^a  

^a UNIVERSITY OF TOKYO HOSPITAL   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^d UNIVERSITY OF TOKYO   (Japan)

Author keywords

CK20; FABP1; Gastric cancer; MUC2; Peritoneal recurrence

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; CK20 PROTEIN; FABP1 PROTEIN; MUCIN 2; TFF1 PROTEIN; TFF2 PROTEIN; TUMOR MARKER; UNCLASSIFIED DRUG;

ARTICLE; CANCER INVASION; DISEASE SEVERITY; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; PERITONEAL BIOPSY; PERITONEUM METASTASIS; PREDICTION; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH CANCER; TUMOR GENE;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOEMBRYONIC ANTIGEN; DISEASE-FREE SURVIVAL; FATTY ACID-BINDING PROTEINS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KAPLAN-MEIER ESTIMATE; KERATIN-20; MUCIN-2; NEOPLASM INVASIVENESS; PEPTIDES; PERITONEAL NEOPLASMS; PREDICTIVE VALUE OF TESTS; RECURRENCE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RISK ASSESSMENT; RISK FACTORS; RNA, MESSENGER; SENSITIVITY AND SPECIFICITY; STOMACH NEOPLASMS; TUMOR SUPPRESSOR PROTEINS;

EID: 84856618287     PISSN: 03682811     EISSN: 14653621     Source Type: Journal    
DOI: 10.1093/jjco/hyr179     Document Type: Article

References (24)

1. Yamazaki H, Oshima A, Murakami R, Endoh S, Ubukata T. A long-term follow-up study of patients with gastric cancer detected by mass screening. Cancer 1989;63:613-7
2. Boku T, Nakane Y, Minoura T, Takada H, Yamamura M, Hioki K, et al. Prognostic significance of serosal invasion and free intraperitoneal cancer cells in gastric cancer. Br J Surg 1990;77:436-9
3. Averbach AM, Jacquet P. Strategies to decrease the incidence of intra-abdominal recurrence in resectable gastric cancer. Br J Surg 1996;83:726-33
4. Bonenkamp JJ, Songun I, Hermans J, van de Velde CJ. Prognostic value of positive cytology findings from abdominal washings in patients with gastric cancer. Br J Surg 1996;83:672-4
5. Wu CC, Chen JT, Chang MC, Ho WL, Chen CY, Yeh DC, et al. Optimal surgical strategy for potentially curable serosa-involved gastric carcinoma with intraperitoneal free cancer cells. J Am Coll Surg 1997;184:611-7
6. Koga S, Kaibara N, Iitsuka Y, Kudo H, Kimura A, Hiraoka H. Prognostic significance of intraperitoneal free cancer cells in gastric cancer patients. J Cancer Res Clin Oncol 1984;108:236-8
7. Bando E, Yonemura Y, Takeshita Y, Taniguchi K, Yasui T, Yoshimitsu Y, et al. Intraoperative lavage for cytological examination in 1,297 patients with gastric carcinoma. Am J Surg 1999;178:256-62
8. Hayes N, Wayman J, Wadehra V, Scott DJ, Raimes SA, Griffin SM. Peritoneal cytology in the surgical evaluation of gastric carcinoma. Br J Cancer 1999;79:520-4
9. Kodera Y, Yamamura Y, Shimizu Y, Torii A, Hirai T, Yasui K, et al. Peritoneal washing cytology: prognostic value of positive findings in patients with gastric carcinoma undergoing a potentially curative resection. J Surg Oncol 1999;72:60-4; discussion 4-5
10. Abe S, Yoshimura H, Tabara H, Tachibana M, Monden N, Nakamura T, et al. Curative resection of gastric cancer: limitation of peritoneal lavage cytology in predicting the outcome. J Surg Oncol 1995;59:226-9
11. Fujimura T, Ohta T, Kitagawa H, Fushida S, Nishimura GI, Yonemura Y, et al. Trypsinogen expression and early detection for peritoneal dissemination in gastric cancer. J Surg Oncol 1998;69:71-5
12. Kodera Y, Nakanishi H, Ito S, Yamamura Y, Kanemitsu Y, Shimizu Y, et al. Quantitative detection of disseminated free cancer cells in peritoneal washes with real-time reverse transcriptase-polymerase chain reaction: a sensitive predictor of outcome for patients with gastric carcinoma. Ann Surg 2002;235:499-506
13. Okada Y, Fujiwara Y, Yamamoto H, Sugita Y, Yasuda T, Doki Y, et al. Genetic detection of lymph node micrometastases in patients with gastric carcinoma by multiple-marker reverse transcriptase-polymerase chain reaction assay. Cancer 2001;92:2056-64
14. Nakanishi H, Kodera Y, Torii A, Hirai T, Yamamura Y, Kato T, et al. Detection of carcinoembryonic antigen-expressing free tumor cells in peritoneal washes from patients with gastric carcinoma by polymerase chain reaction. Jpn J Cancer Res 1997;88:687-92
15. Fujii S, Kitayama J, Kaisaki S, Sasaki S, Seto Y, Tominaga O, et al. Carcinoembryonic antigen mRNA in abdominal cavity as a useful predictor of peritoneal recurrence of gastric cancer with serosal exposure. J Exp Clin Cancer Res 2002;21:547-53
16. Marutsuka T, Shimada S, Shiomori K, Hayashi N, Yagi Y, Yamane T, et al. Mechanisms of peritoneal metastasis after operation for non-serosa-invasive gastric carcinoma: an ultrarapid detection system for intraperitoneal free cancer cells and a prophylactic strategy for peritoneal metastasis. Clin Cancer Res 2003;9:678-85
17. Oyama K, Terashima M, Takagane A, Maesawa C. Prognostic significance of peritoneal minimal residual disease in gastric cancer detected by reverse transcription-polymerase chain reaction. Br J Surg 2004;91:435-43
18. Tokuda K, Natsugoe S, Nakajo A, Miyazono F, Ishigami S, Hokita S, et al. Clinical significance of CEA-mRNA expression in peritoneal lavage fluid from patients with gastric cancer. Int J Mol Med 2003;11:79-84
19. Ueno H, Yoshida K, Hirai T, Kono F, Kambe M, Toge T. Quantitative detection of carcinoembryonic antigen messenger RNA in the peritoneal cavity of gastric cancer patients by real-time quantitative reverse transcription polymerase chain reaction. Anticancer Res 2003;23:1701-8
20. Yonemura Y, Endou Y, Fujimura T, Fushida S, Bandou E, Kinoshita K, et al. Diagnostic value of preoperative RT-PCR-based screening method to detect carcinoembryonic antigen-expressing free cancer cells in the peritoneal cavity from patients with gastric cancer. ANZ J Surg 2001;71:521-8
21. Nagao K, Hisatomi H, Hirata H, Yamamoto S, Hikiji K, Yamamoto M, et al. Expression of molecular marker genes in various types of normal tissue: implication for detection of micrometastases. Int J Mol Med 2002;10:307-10
22. Mori K, Aoyagi K, Ueda T, Danjoh I, Tsubosa Y, Yanagihara K, et al. Highly specific marker genes for detecting minimal gastric cancer cells in cytology negative peritoneal washings. Biochem Biophys Res Commun 2004;313:931-7
23. Kodera Y, Nakanishi H, Yamamura Y, Shimizu Y, Torii A, Hirai T, et al. Prognostic value and clinical implications of disseminated cancer cells in the peritoneal cavity detected by reverse transcriptase-polymerase chain reaction and cytology. Int J Cancer 1998;79:429-33
24. Paoletti X, Oba K, Burzykowski T, Michiels S, Ohashi Y, Pignon JP, et al. Benefit of adjuvant chemotherapy for resectable gastric cancer: a meta-analysis. JAMA 2010;303:1729-37